# ZNFX1

## Overview
ZNFX1 is a gene that encodes the protein zinc finger NFX1-type containing 1, which functions as a double-stranded RNA (dsRNA) sensor in the human immune system. This protein is categorized as an interferon-stimulated gene product and plays a pivotal role in the antiviral immune response by recognizing viral nucleic acids and promoting the expression of interferon-stimulated genes (ISGs). ZNFX1 is essential for the posttranscriptional regulation of ISGs, ensuring a balanced immune response to viral infections. The protein interacts with viral RNA and the mitochondrial antiviral signaling (MAVS) protein, facilitating a type I interferon-mediated response. Mutations in the ZNFX1 gene can lead to severe immunodeficiency disorders, highlighting its critical role in maintaining immune homeostasis (Vavassori2021Multisystem).

## Function
ZNFX1 is a gene that encodes a highly conserved interferon-stimulated double-stranded RNA (dsRNA) sensor, playing a crucial role in the human immune response. In healthy human cells, ZNFX1 is involved in recognizing viral nucleic acids, which triggers a type I interferon-mediated antiviral immune response. This gene is typically expressed at low levels in uninfected cells but is rapidly upregulated in response to viral infections and exposure to type I interferons. ZNFX1 binds to viral RNA and interacts with the mitochondrial antiviral signaling (MAVS) protein, promoting the expression of interferon-stimulated genes (ISGs) (Vavassori2021Multisystem).

ZNFX1 is required for the posttranscriptional regulation of ISGs, influencing their expression stability and ensuring a balanced interferon response. This regulation is essential for a less inflammatory but more protective immune response, highlighting ZNFX1's role in balancing the innate immune response to viral infections (Vavassori2021Multisystem). The proper function of ZNFX1 is essential for the balanced induction of ISGs, which are critical for the immune system's ability to clear viral infections (Vavassori2021Multisystem).

## Clinical Significance
Mutations in the ZNFX1 gene are associated with severe immunodeficiency disorders characterized by increased susceptibility to viral infections and multisystem inflammatory diseases. Patients with ZNFX1 deficiency often experience severe inflammatory episodes affecting major organs such as the liver, brain, kidneys, and lungs. These episodes can resemble hemophagocytic lymphohistiocytosis (HLH), a condition marked by excessive immune activation (Vavassori2021Multisystem). The deficiency is linked to a deregulated expression of interferon-stimulated genes (ISGs), impairing the body's ability to clear viral infections effectively (Vavassori2021Multisystem).

Clinical manifestations of ZNFX1 mutations include recurrent viral and mycobacterial infections, monocytosis, thrombocytopenia, hepatosplenomegaly, and HLH-like symptoms (AlSaud2023ZNFX1). In some cases, patients present with interstitial pneumonitis and renal disease, alongside abnormalities in the B cell compartment (AlSaud2023ZNFX1). The high mortality rate associated with ZNFX1 deficiency underscores its clinical significance, with many patients succumbing to severe infections and inflammatory complications during childhood (Vavassori2021Multisystem). Genetic analysis has identified various mutations, including truncating and missense variants, which contribute to the disease phenotype (Vavassori2021Multisystem).

## Interactions
ZNFX1 is a protein that plays a crucial role in the immune response by acting as a sensor for double-stranded RNA, particularly in the context of viral infections. It interacts with viral RNA and the mitochondrial antiviral signaling (MAVS) protein, promoting the expression of interferon-stimulated genes (ISGs) (Vavassori2021Multisystem). This interaction is essential for the induction of a type I interferon-mediated antiviral response, although ZNFX1's signaling does not rely on other MAVS-associated sensors like RIG-I and MDA5 (Vavassori2021Multisystem).

ZNFX1 is also involved in the posttranscriptional regulation of ISGs, influencing their stability and expression in response to double-stranded nucleic acids. This regulation is vital for maintaining a balanced interferon response, preventing excessive inflammation while ensuring protection against infections (Vavassori2021Multisystem). In the absence of ZNFX1, there is a hyperresponse to intracellular RNA and DNA, which enhances interferon responses, whereas extracellular RNA induces apoptosis-related gene expression (Vavassori2021Multisystem).

These interactions highlight ZNFX1's role in balancing viral sensing and the innate immune response, acting as a buffer to modulate the inflammatory response and ensuring effective viral clearance (Vavassori2021Multisystem).


## References


[1. (Vavassori2021Multisystem) Stefano Vavassori, Janet Chou, Laura Eva Faletti, Veronika Haunerdinger, Lennart Opitz, Pascal Joset, Christopher J. Fraser, Seraina Prader, Xianfei Gao, Luise A. Schuch, Matias Wagner, Julia Hoefele, Maria Elena Maccari, Ying Zhu, George Elakis, Michael T. Gabbett, Maria Forstner, Heymut Omran, Thomas Kaiser, Christina Kessler, Heike Olbrich, Patrick Frosk, Abduarahman Almutairi, Craig D. Platt, Megan Elkins, Sabrina Weeks, Tamar Rubin, Raquel Planas, Tommaso Marchetti, Danil Koovely, Verena Klämbt, Neveen A. Soliman, Sandra von Hardenberg, Christian Klemann, Ulrich Baumann, Dominic Lenz, Andreas Klein-Franke, Martin Schwemmle, Michael Huber, Ekkehard Sturm, Steffen Hartleif, Karsten Häffner, Charlotte Gimpel, Barbara Brotschi, Guido Laube, Tayfun Güngör, Michael F. Buckley, Raimund Kottke, Christian Staufner, Friedhelm Hildebrandt, Simone Reu-Hofer, Solange Moll, Achim Weber, Hundeep Kaur, Stephan Ehl, Sebastian Hiller, Raif Geha, Tony Roscioli, Matthias Griese, and Jana Pachlopnik Schmid. Multisystem inflammation and susceptibility to viral infections in human znfx1 deficiency. Journal of Allergy and Clinical Immunology, 148(2):381–393, August 2021. URL: http://dx.doi.org/10.1016/j.jaci.2021.03.045, doi:10.1016/j.jaci.2021.03.045. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2021.03.045)

[2. (AlSaud2023ZNFX1) Bandar Al-Saud, Ibrahim Al-Mogarri, Huda Alajlan, Fadia Alkhattabi, Ali Al-Ahmari, Mohammed Alowain, Turki Alshareef, Monther Al-Alwan, and Anas M. Alazami. Znfx1 deficiency in a child with interstitial pneumonitis and peripheral monocytosis. Journal of Clinical Immunology, 43(7):1529–1532, June 2023. URL: http://dx.doi.org/10.1007/s10875-023-01529-0, doi:10.1007/s10875-023-01529-0. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-023-01529-0)